Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma-Reference-Cited by-同舟云学术

Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma

Published:2014-09-19 Issue:8 Volume:136 Page:1835-1844
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Hao Mu¹,Zang Meirong¹,Wendlandt Erik²,Xu Yan¹,An Gang¹,Gong Dasen³,Li Fei¹,Qi Fang¹,Zhang Yanru¹,Yang Ye²,Zhan Fenghuang²,Qiu Lugui¹

Affiliation:

1. State Key Laboratory of Experimental Hematology; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College; Tianjin China

2. Division of Hematology; Oncology; and Blood and Marrow Transplantation; Department of Internal Medicine; University of Iowa; Iowa City IA

3. Tianjin Neurological Institute, Tianjin Medical University General Hospital; Tianjin China

Funder

National Natural Science Foundation of China

Tianjin Science and Technology Supporting Program

Foundation of MOE of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference58 articles.

1. Multiple myeloma;Raab;Lancet,2009

2. Multiple myeloma;Anderson;Hematology Am Soc Hematol Educ Program,2002

3. The cellular architecture of multiple myeloma;Vicente-Duenas;Cell Cycle,2012

4. RARalpha2 expression confers myeloma stem cell features;Yang;Blood,2013

5. NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers;Zhou;Cancer Cell,2013

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the clinical landscape: Update on the diagnostic and prognostic biomarkers in multiple myeloma;Molecular Biology Reports;2024-09-09

2. Highlighting the role of long non-coding RNA (LncRNA) in multiple myeloma (MM) pathogenesis and response to therapy;Medical Oncology;2024-06-07

3. CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy;eBioMedicine;2024-02

4. Epigenetic modification of miRNA in cancer;Personalized Epigenetics;2024

5. The Role of MicroRNAs in Mature B-Cell Neoplasias Drug Resistance;Comprehensive Hematology and Stem Cell Research;2024